The Hedgehog Signalling Pathway in the Gastrointestinal Tract: Implications for Development, Homeostasis, and Disease  Charlie Lees, Sarah Howie, R. Balfour.

Slides:



Advertisements
Similar presentations
Patched and Basal Cell Carcinoma Matt Darch. Patched.
Advertisements

Date of download: 6/21/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. The hedgehog (Hh) signaling—a proliferative pathway especially.
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma  André Veillette, Huaijian Guo  Critical Reviews.
Alexander Loewer, Galit Lahav  Cell 
Volume 76, Issue 9, Pages (November 2009)
Cellular and Molecular Mechanisms of Liver Injury
Biologic therapy of inflammatory bowel disease
Notch signaling and new therapeutic options in liver disease
Volume 18, Issue 6, Pages R238-R241 (March 2008)
“Atypical” Regulation of Hedgehog-Dependent Cancers
Volume 129, Issue 2, Pages (August 2005)
D.H. Dockrell  Clinical Microbiology and Infection 
Byeong–Moo Kim, Michael Y. Choi  Gastroenterology 
Cellular and Molecular Mechanisms of Liver Injury
Hedgehog signaling in the liver
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Biologic therapy of inflammatory bowel disease
New class of anti-inflammatory agents for colonic epithelial cells
The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy  John D. O’Flaherty, MB, BCh, BAO, Martin.
Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro  Min You, PhD, Javier Varona-Santos,
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Bhagelu Ram Achyut, Li Yang  Gastroenterology 
Ella H. Sklan, Jeffrey S. Glenn  Gastroenterology 
Volume 148, Issue 7, Pages (June 2015)
The Two Faces of Receptor Interacting Protein Kinase-1
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
A. Craig Lockhart, Mace L. Rothenberg, Jordan D. Berlin 
Volume 23, Issue 1, Pages (January 2013)
Hedgehog Signaling: Is Smo a G Protein-Coupled Receptor?
Sumoylation Stabilizes Smoothened to Promote Hedgehog Signaling
Volume 76, Issue 9, Pages (November 2009)
Hedgehog and Patched in Neural Development and Disease
Edwina S. Baskin–Bey, Gregory J. Gores  Gastroenterology 
Joshua E. Allen, Wafik S. El-Deiry  Gastroenterology 
Pharmacodynamic Dr. Hashem Mansour.
Met as a therapeutic target in HCC: Facts and hopes
Structural Mechanism of RNA Recognition by the RIG-I-like Receptors
Robert J. Lefkowitz, Keshava Rajagopal, Erin J. Whalen  Molecular Cell 
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Michael S. Hildebrand, Nicole G. Griffin, John A. Damiano, Elisa J
Lack of Evidence for Activation of the Hedgehog Pathway in Psoriasis
Smad proteins and transforming growth factor-β signaling
Molecular Mechanisms Regulating Hair Follicle Development
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
CDK Inhibitors: Cell Cycle Regulators and Beyond
Death receptor-mediated apoptosis and the liver
Proteins Kinases: Chromatin-Associated Enzymes?
Caspases and Kinases in a Death Grip
Volume 123, Issue 6, Pages (December 2002)
Erik G. Huntzicker, Anthony E. Oro 
Hedgehog signalling: off the shelf modulation
Ekaterina Pak, Rosalind A. Segal  Developmental Cell 
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
How Bad Is the Hedgehog? GLI-Dependent, Hedgehog-Independent Cancers on the Importance of Biomarkers for Proper Patients Selection  Delphine Javelaud,
Volume 14, Issue 4, Pages (October 2008)
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Figure 1 Extrinsic and intrinsic pathways of apoptosis
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Smoothing Out Drug Resistance
A possible mechanism of renal cell death after ischemia/reperfusion
Shared Principles in NF-κB Signaling
Volume 18, Issue 6, Pages R238-R241 (March 2008)
Hedgehog Signaling in Development and Cancer
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety  Philippe Bouchard, M.D., Nathalie Chabbert-Buffet,
Ma. Xenia G. Ilagan, Raphael Kopan  Cancer Cell 
Heather M. Young, Lincon A. Stamp  Gastroenterology 
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
Characterization of the MM.1 human multiple myeloma (MM) cell lines
Update on glucocorticoid action and resistance
Presentation transcript:

The Hedgehog Signalling Pathway in the Gastrointestinal Tract: Implications for Development, Homeostasis, and Disease  Charlie Lees, Sarah Howie, R. Balfour Sartor, Jack Satsangi  Gastroenterology  Volume 129, Issue 5, Pages 1696-1710 (November 2005) DOI: 10.1053/j.gastro.2005.05.010 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Hh signalling in mammalian cells. In the absence of Hh protein (A), the 12-transmembrane domain receptor Ptc exerts an inhibitory effect on Smo, a 7-pass transmembrane protein with homology to G-protein–coupled receptors. Smo, in complex with Cos-2, prevents nuclear availability of the full Gli product.116 This occurs by a combination of microtubule binding of the complex and proteolysis to a truncated Gli (GliTR). Furthermore, when Ptc is unoccupied by Hh, it is suggested that caspase-3 (casp-3) cleavage of its intra-cellular portion exposes a receptor region that transduces an apoptotic signal via Gli-3. In the presence of Hh ligand-binding (B), the inhibitory action of Ptc on Smo is released. The full Gli product is now stabilized and transferred to the nucleus. This process is likely mediated in part by conformational change in the Cos-2/Gli/Fu complex and also by interaction of Gli with a phosphorylated Su (Fu). Once in the nucleus, the full Gli product binds to and up-regulates transcriptional targets, including Ptc and another Hh-binding protein, HIP. In this manner, excess Hh is sequestered, and control is exerted on the pathway. Gastroenterology 2005 129, 1696-1710DOI: (10.1053/j.gastro.2005.05.010) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Methods of agonizing/antagonizing the Hh signalling pathway. Shh ligand can be prevented from binding to its receptor, Ptc, by an anti-Shh monoclonal antibody 5E1.117 Several specific Smo inhibitors have been identified. Cyclopamine is a natural alkaloid derivate isolated from Veratum californicum, a plant of the lily family long known to be teratogenic to grazing pregnant ewes.118–121 Although impractical for human therapeutics because of difficulties of large-scale production, blocking Hh signalling with cyclopamine does appear safe in treated mice.85,88 Pka agonists such as Forskolin can decrease pathway activity as they maintain the Gli family of transcription factors in an inactive state. Alternatively blocking Gli RNA with antisense oligonucleotides has been shown to abrogate successfully the Hh pathway activity in Xenopus.122 Curis Inc. has developed a small molecule Hh agonist (in partnership with Wyeth) and an antagonist (with Genentech) that have been tested in preclinical models and are now being evaluated in phase I clinical trials (http://www.curis.com). Gastroenterology 2005 129, 1696-1710DOI: (10.1053/j.gastro.2005.05.010) Copyright © 2005 American Gastroenterological Association Terms and Conditions